Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (BRAVO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03396575
Recruitment Status : Recruiting
First Posted : January 11, 2018
Last Update Posted : March 7, 2019
Sponsor:
Collaborators:
Accelerate Brain Cancer Cure
Lyla Nsouli Foundation
Information provided by (Responsible Party):
University of Florida

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2020
  Estimated Study Completion Date : June 2022